Today

Agents

Chat

Arena

Discover

More

App

Brief-Monte Rosa Therapeutics Q2 Collaboration Revenue USD 8.968 Million - GLUE News | Rallies

Brief-Monte Rosa Therapeutics Q2 Collaboration Revenue USD 8.968 Million

GLUE•2026-08-06

Q2 collaboration revenue and expenses

Aug. 6 (Reuters) - Monte Rosa Therapeutics Q2 collaboration revenue was $8.968 million.

Q2 operating expenses: $58.098 million
Q2 operating income: -$49.13 million
Q2 net income: -$43.397 million

Related News

Safe Harbor 401(k) plan wins Canopy HR endorsement for cannabis clients

SHFS•2026-08-06

Praxis Precision Q2 EPS USD -2.87

PRAX•2026-08-06

Twin Vee Q2 FY26 net loss widens 75% to $2.9 million; net sales drop 34% to $3.13 million

2026-08-06

Keurig Dr Pepper reaffirms forecast on strong soda, energy drink demand

KDP•2026-08-06

ALX Oncology Q2 Basic EPS USD -0.13

ALXO•2026-08-06